Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)

Stable Identifier
R-HSA-5619072
Type
Pathway
Species
Homo sapiens
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)
Click the image above or here to open this pathway in the Pathway Browser
The human gene SLC35A2 encodes the UDP-galactose transporter. It is located on the Golgi membrane and mediates the antiport of UDP-Gal into the Golgi lumen in exchange for UMP. Nucleotide sugars such as UDP-Gal are used in protein glycosylation in the Golgi lumen. This transporter is also known to transport UDP-N-acetylgalactosamine (UDP-GalNAc) by the same antiport mechanism. Defects in SLC35A2 limit Golgi-localised pools of UDP-Gal, resulting in truncated beta-GlcNAc-terminated N-glycans and alpha-GalNAc-terminated O-glycans. Defects in SLC35A2 can cause congenital disorder of glycosylation 2M (CDG2M; MIM:300896), a disorder characterised by developmental delay, hypotonia, ocular defects and brain malformations (Ng et al. 2013). Congenital disorders of glycosylation (CDGs) are generally characterised by under-glycosylated serum glycoproteins and a wide spectrum of clinical features. Defects in SLC35A2 can also cause early infantile epileptic encephalopathy 22 (EIEE22; MIM:300896), a severe form of epilepsy characterised by by frequent tonic seizures or spasms beginning in infancy and accompanied by developmental problems (Kodera et al. 2013).
Literature References
PubMed ID Title Journal Year
23561849 Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation

Chong, JX, Raymond, K, Bamshad, MJ, Gilbert, RD, He, M, Li, C, Kozenko, M, Ng, BG, Nickerson, DA, Turner, EH, Kircher, M, Losfeld, ME, Smith, JD, Buckingham, KJ, Shendure, J, Szybowska, M, Patterson, MC, Eroshkin, A

Am. J. Hum. Genet. 2013
24115232 De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy

Miyake, N, Nishiyama, K, Saitsu, H, Osaka, H, Wada, Y, Tsurusaki, Y, Kondo, Y, Haginoya, K, Sugahara, K, Matsumoto, N, Mizumoto, S, Nakamura, K, Yuasa, I, Nakashima, M, Iai, M, Kodera, H, Hayasaka, K, Maegaki, Y, Okamoto, N, Kato, M

Hum. Mutat. 2013
Participants
Events
Participates
as an event of
Disease
Authored
Jassal, B  (2014-08-22)
Reviewed
Broer, S  (2015-08-04)
Created
Jassal, B  (2014-08-22)
Cite Us!